Close Menu

NEW YORK (GenomeWeb) – Agilent Technologies reported after the close of the market on Wednesday that its first quarter 2019 revenues rose 6 percent year over year, thanks largely to a 13 percent increase in revenues in its diagnostics and genomics business.

For the three months ended Jan. 31, the firm said revenues rose to $1.28 billion from $1.21 billion in Q1 2018, beating the Wall Street analysts' average estimate of $1.27 billion. The company said core revenues also grew 6 percent in Q1.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Researchers in India plan to sequence SARS-CoV-2 isolates from around the country, according to LiveMint.

Mauro Ferrari has resigned as president of the European Research Council over its response to the COVID-19 pandemic, the Financial Times reports.

Stat News reports some health tech startups are laying off or furloughing workers.

In Genome Research this week: indels affecting microsatellites in cancer, analytical approach to find key regulatory elements, and more.